DIGEST LIVER DIS 润色咨询

DIGESTIVE AND LIVER DISEASE

出版年份:2000 年文章数:1906 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2020-10-18 1248756em59(暂无昵称)

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2024-02-12 ms6000000536352595 来自陕西省

    images of the month和case有啥区别呢?这个杂志

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-04-01 ms4000000223433444 来自山东省

    digestive and liver disease是需要所有读者认证吗?求助

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-08-21 左手摸机 来自浙江省

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-11-04 ms4000002096191420 来自广西

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-09-15 ms6000000656125557 来自云南省

    这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2022-11-03 RamonaHWW

    请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-05-24 ms6000001767911714 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:消化系统良性疾病
    经验分享:5.19 投,5.22 拒,没有写理由,很伤心

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-04-17 ms1000002026392296 来自甘肃省

    偏重的研究方向:肝细胞癌;肝病
    经验分享:请问大家,这个杂志接受meta吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:系统不会提示审阅进程,如果两周没回复应该就是送外审了,我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢?这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗?求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:14号投稿,15号给的稿号,20号收到elsvier已送外审邮件,杂志官网不显示稿件状态!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:这个杂志速度没有想象的那么快,编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗,我看images of the month栏目是以case report 的形式,有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位,投稿将近20+d,现处于submission being processed for author状态是已经送审了嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138882, encodeId=a1b6213888213, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:消化系统良性疾病<br>经验分享:5.19 投,5.22 拒,没有写理由,很伤心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aeb8182236, createdName=ms6000001767911714, createdTime=Wed May 24 21:23:54 CST 2023, time=2023-05-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126581, encodeId=caa3212658106, content=偏重的研究方向:肝细胞癌;肝病<br>经验分享:请问大家,这个杂志接受meta吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f6151830, createdName=ms1000002026392296, createdTime=Mon Apr 17 20:52:50 CST 2023, time=2023-04-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2148637, encodeId=1682214863e02, content=偏重的研究方向:消化道;肿瘤<br>经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Tue Jul 18 18:02:42 CST 2023, time=2023-07-18, status=1, ipAttribution=北京)]
    2023-07-18 ms2000002077912665 来自北京

    偏重的研究方向:消化道;肿瘤
    经验分享:这个杂志投稿以后貌似看不到状态,只能等邮件通知?

    0

共132条页码: 1/14页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分